Phase Ⅰ Clinical Trial of Gerilimzumab Injection in Healthy Subjects

Clinical trial NCT04178070 · UNKNOWN

Trial details

NCT number: NCT04178070
Sponsor: Genor Biopharma Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2017-11-06
Primary completion: 2020-12-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.